KF
Keith T. Flaherty is a clinical investigator at Massachusetts General Hospital. His research focuses on melanoma and targeted cancer therapies, including clinical trials of kinase inhibitors and immunotherapy regimens. He has contributed to studies of personalized treatment for BRAF-mutant melanoma.
- Field
- Medicine · Oncology
- Clarivate categories
- Cross-Field
- Affiliation
- Massachusetts General Hospital, United States